About
About Endurance RP Limited
Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.
Visit company website
5 years, 5 months ago
Regent Pacific Group Limited is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 573.0% more expensive than other stocks from the Financial Services sector with a price to sales ratio of 99.7.
Regent Pacific Group Limited's total revenue sank by 83.9% to $85K since the same quarter in the previous year.
Its net income has increased by 36.5% to $-27M since the same quarter in the previous year.
Finally, its free cash flow fell by 71.5% to $-4M since the same quarter in the previous year.
Based on the above factors, Regent Pacific Group Limited gets an overall score of 1/5.